TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AEHR

Aehr Test Systems

Technology · Semiconductor Equipment & Materials · listed since 1997

51.50$ -6.2% vs. previous close Closing price · As of: Nov 2, 2026
🔔 Watch stock
Add to watchlist

Share this page

LinkedIn WhatsApp Email

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

No substance risk: $116.4 million in cash, no financial debt, minimal cash burn, a clean audit opinion. But the central operating question is open — whether $80.6 million in backlog really turns into $130 million to $150 million in revenue and a pre-tax profit is announced, not proven, and it depends on a few large customers. At a market value of roughly $2.0 billion, that outcome is already largely priced in. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Aehr Test Systems sits between an order book that quintupled within a year to $80.6 million and revenue that shrank two years in a row to $50.0 million. The old engine, electric vehicles (92 percent of revenue in fiscal 2024, 17 percent in fiscal 2026), has stalled; AI processors and silicon photonics are meant to replace it, and management promises $130 million to $150 million for fiscal 2027. The balance sheet is debt-free and well stocked — paid for with roughly 1.94 million new shares while insiders sold roughly 677,000 in the open market. Not investment advice.

Order situation

Backlog rose from $15.2 million (May 30, 2025) to $80.6 million (May 29, 2026), and fourth-quarter bookings hit a record $60.7 million; management guides to $130 million to $150 million in revenue for the fiscal year ending June 25, 2027 (8-K, July 14, 2026).

Revenue and profitability

Revenue fell two years in a row ($66.2 million → $59.0 million → $50.0 million), gross margin dropped from 49.1 to 35.3 percent, and fiscal 2026 brought a pre-tax loss of $11.7 million; even the record fourth quarter of fiscal 2026 was −$0.5 million before taxes (10-K, July 27, 2026).

Customer concentration

The five largest customers accounted for 70 percent of fiscal 2026 revenue, the largest for 26 percent; in fiscal 2024 a single customer had brought in 67 percent. Dependence is declining, but the 2027 guidance hinges on a few anchor customers (10-K 2026, Item 1A).

Balance sheet and liquidity

$116.4 million in cash, no financial debt, total liabilities of $27.2 million and shareholders' equity of $219.5 million as of May 29, 2026; operating cash outflow was just $3.3 million in fiscal 2026 (10-K, July 27, 2026).

Dilution and insiders

Roughly 1.94 million new shares in fiscal 2026 (share count up just over 9 percent through August 27, 2026); in parallel, executives and board directors sold roughly 677,000 shares for about $60.1 million in the open market between April 9 and August 17, 2026, with no flagged 10b5-1 plan (Form 4 incl. Form 4/A).

Worth Noting

Fiscal year: fiscal 2026 ran from May 31, 2025, through May 29, 2026. From 2027 on, the fiscal year ends on the Friday closest to June 30 (fiscal 2027: June 27, 2026, to June 25, 2027); the four weeks in between will be included in the first quarterly report for the quarter ended September 25, 2026, which had not been filed as of our press date (October 18, 2026).

Price data dated and evergreen: $9.54 (May 30, 2025), high of $145.61 (August 17, 2026), price anchor $60.60 (October 16, 2026); analyses are evergreen, daily prices are not a buy argument.

Fiscal 2024 net income ($33.2 million) includes the release of a $21.9 million valuation allowance on deferred tax assets; pre-tax income was $12.5 million. For year-over-year comparisons, pre-tax income is therefore more meaningful.

Stock Watch

This analysis is as of October 18, 2026. Stock Watch will tell you what's changed at AEHR since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 19.40 $ to 145.60 $ · Last price: 51.50 $ (As of: November 2, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.6$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 33m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.6%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 3.5

Performance

Perf. 1M ?Price performance over the last month. -5.20%
Perf. 3M ?Price performance over the last 3 months. 191.40%
Perf. 6M ?Price performance over the last 6 months. 329.40%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 407.10%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -22.0%
Perf. 1Y ?Price performance over the last 12 months. 98.04%
Perf. 3Y ?Price performance over the last 3 years. 108.13%
Perf. 5Y ?Price performance over the last 5 years. 119.30%
Perf. 10Y ?Price performance over the last 10 years. 1,513.48%
Perf. Since Inception ?Price performance since the first available trading day (08/15/1997) — with a complete history, that is since the IPO. 248.95%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 81.40$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 82.70$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 74.50$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 30.5
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 97.0%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 122.3%

Calculated from the price history · as of 11/03/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. –
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 73.5
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 0.5
P/B ?Price-to-book ratio: market value relative to book equity. 10.6
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 32.4
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 29.8
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. –

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 35.3%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. -41.0%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. -14.2%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -8.7%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -4.5%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 88.4%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.1
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 13.57
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. weak 2 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -43.70%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). -87.50%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -10.95%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 70.85%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 257.90%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. Top 10% 99
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 4
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (56 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Semiconductor Equipment & Materials

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Aehr Test Systems AEHR 1.6 – 29.8 35.3 -41.0 -11.0 98.0
ASML Holding N.V. New York Registry Shares ASML 567.7 51.4 34.6 54.3 37.1 15.6 45.0
Lam Research Corp LRCX 313.9 40.1 30.5 51.1 35.0 23.7 45.2
Applied Materials Inc AMAT 297.3 32.5 28.9 49.4 31.9 4.4 61.6
KLA Corporation KLAC 200.0 41.2 30.5 61.5 41.2 23.9 27.4
Teradyne Inc TER 42.6 42.8 32.2 59.2 37.6 13.1 55.4
Entegris Inc ENTG 25.3 76.1 26.9 45.6 18.0 -1.4 77.0
Qnity Electronics, Inc Q 24.2 46.1 19.8 46.2 22.8 9.7 25.2
Onto Innovation Inc ONTO 10.5 83.0 39.1 55.5 16.8 1.8 47.1
Median of companies shown 42.6 44.4 30.5 51.1 31.9 9.7 47.1

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2017 · Revenue: 19 $M 2017 · Operating income: -5 $M 2017 · Net income: -6 $M 2018 · Revenue: 30 $M 2018 · Operating income: 1 $M 2018 · Net income: 1 $M 2019 · Revenue: 21 $M 2019 · Operating income: -4 $M 2019 · Net income: -5 $M 2020 · Revenue: 22 $M 2020 · Operating income: -3 $M 2020 · Net income: -3 $M 2021 · Revenue: 17 $M 2021 · Operating income: -4 $M 2021 · Net income: -2 $M 2022 · Revenue: 51 $M 2022 · Operating income: 8 $M 2022 · Net income: 9 $M 2023 · Revenue: 65 $M 2023 · Operating income: 13 $M 2023 · Net income: 15 $M 2024 · Revenue: 66 $M 2024 · Operating income: 10 $M 2024 · Net income: 33 $M 2025 · Revenue: 59 $M 2025 · Operating income: -4 $M 2025 · Net income: -4 $M 2026 · Revenue: 50 $M 2026 · Operating income: -14 $M 2026 · Net income: -7 $M
2017201820192020202120222023202420252026
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2017 19 -5 -6 -0.35 -5 17 31
2018 30 1 1 0.02 -1 19 31
2019 21 -4 -5 -0.23 -6 15 21
2020 22 -3 -3 -0.12 -2 14 21
2021 17 -4 -2 -0.09 -3 11 22
2022 51 8 9 0.34 2 51 62
2023 65 13 15 0.50 10 76 98
2024 66 10 33 1.12 2 112 128
2025 59 -4 -4 -0.13 -7 123 149
2026 50 -14 -7 -0.23 -3 220 247

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 13.5 $M Q4 2025: Q1 · 18.3 $M Q1 2025: Q2 · 14.1 $M Q2 2025: Q3 · 11.0 $M Q3 2025: Q4 · 9.9 $M Q4 2026: Q1 · 10.3 $M Q1 2026: Q2 · 18.8 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.03 -116.90 14 -37.20 -7.60 -6 -6
2025: Q1 -0.02 – 18 142.10 -3.50 -2 -3
2025: Q2 -0.10 -112.00 14 -15.10 -20.60 -2 -5
2025: Q3 -0.07 -412.70 11 -16.40 -19.00 0 -2
2025: Q4 -0.11 – 10 -26.50 -32.70 -1 -2
2026: Q1 -0.10 – 10 -43.70 -31.10 -3 -3
2026: Q2 0.05 150.00 19 33.30 7.40 2 2

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 15 of our scanner strategies — each hit links to the scanner.

Backtested Scanners

Quality & Balance Sheet

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 6
Price Target (average) 128.00$
Distance to price 148.5% The price target sits 148.5% above the current price.

Distribution of Recommendations

Strong Buy 6
Buy 0
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
05/31/2027 0.75 0.70 – 0.78 136 2,400.0% 3
06/30/2027 0.77 0.74 – 0.80 138 2,466.7% 3
05/31/2028 1.38 1.13 – 1.54 202 84.4% 3

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Sells AI

Aehr verkauft Burn-in-Testsysteme, die laut Geschäftsbericht 2026 eigens für KI-Beschleuniger und Grafikprozessoren ausgelegt sind (Sonoma-Linie), und weist in Geschäfts- und Quartalsberichten Umsatzwachstum mit Kunden aus KI-Anwendungen aus — KI-Chip-Test ist damit nachweislich Umsatzquelle.

View the full file — quotes, sources, reviewed filings
„The Sonoma line, with its ultra-high-power capabilities, is specifically designed to address the reliability and burn-in needs of the burgeoning demand for AI accelerators, GPUs, HPC processors, and devices that can reach levels of power as high as 1600 or more watts."

Die Sonoma-Linie mit ihren Ultrahochleistungs-Fähigkeiten ist eigens dafür ausgelegt, den Zuverlässigkeits- und Burn-in-Bedarf der stark wachsenden Nachfrage nach KI-Beschleunigern, Grafikprozessoren, Hochleistungsrechner-Prozessoren und Bauteilen zu decken, die Leistungen von 1.600 Watt oder mehr erreichen können.

10-K · 2026-07-27 · View SEC filing

„This decline was partially offset by revenue growth in the United States, driven by much higher systems and contactors sales to customers that focus on the artificial intelligence market."

Dieser Rückgang wurde teilweise durch Umsatzwachstum in den Vereinigten Staaten ausgeglichen, getragen von deutlich höheren Verkäufen von Systemen und Kontaktoren an Kunden, die sich auf den Markt für künstliche Intelligenz konzentrieren.

10-K · 2026-07-27 · View SEC filing

„Contactors revenue decreased by $5.1 million, partially offset by an increase in package-level burn-in systems revenue of $1.6 million, driven by increased demand from customers in AI-related applications."

Der Umsatz mit Kontaktoren sank um 5,1 Millionen US-Dollar, teilweise ausgeglichen durch einen Anstieg des Umsatzes mit Burn-in-Systemen für verpackte Chips um 1,6 Millionen US-Dollar, getragen von höherer Nachfrage von Kunden mit KI-bezogenen Anwendungen.

10-Q · 2026-01-12 · View SEC filing

Filings Reviewed: 10-K 2026-07-27 · 10-K 2025-07-28 · 10-Q 2026-04-08 · 10-Q 2026-01-12 · 10-Q 2025-10-08 · 10-Q 2025-04-10

Rated on October 18, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

4 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -8.4%
  • More than 10% revenue growth is expected for the coming year 70.9%
  • Share count grows by less than 3% a year 1.6%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -26.0%
  • Gross margin at 40% or higher and without meaningful erosion 35.3%
  • Goodwill from acquisitions does not grow faster than revenue 4.4%
  • Net debt below twice EBITDA 106 m net cash
  • Operating cash flow covers the profits of the last three years -31 m
  • Return on capital at 15% or higher, or up versus two years ago -6.2%
  • Insiders hold at least 10% or are net buyers 4.6%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

5/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 11.4%
  • Exp. sales growth 3Y > 5% 59.2%
  • EBIT growth 10Y > 5% –
  • Exp. EBIT growth 3Y > 5% 59.2%
  • Net debt < 4x EBIT –
  • EBIT positive, 10Y straight 4
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% -3.6%
  • ROCE > 15% -6.2%
  • Expected return > 10% 58.7%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Oct 28, 2026 Vijayrao Narsing Krishna Director Other 2,169 0.00 –
Oct 27, 2026 Sporck Alistair N VP Contactor Business Unit Other 188 63.95 12,023
Oct 27, 2026 Rogers Vernon Exec VP of Sales & Mktg. Other 197 63.95 12,598
Oct 27, 2026 Richmond Donald P. Ii CTO Other 145 63.95 9,273
Oct 27, 2026 Erickson Gayn President and CEO Other 851 63.95 54,421
Oct 27, 2026 Engineer Adil Chief Operating Officer Other 202 63.95 12,918
Oct 20, 2026 Posedel Rhea J Director Other 18,000 1.77 31,860
Oct 12, 2026 Siu Chris CFO Other 987 84.64 83,540
Oct 12, 2026 Sporck Alistair N VP Contactor Business Unit Other 295 84.64 24,969
Oct 12, 2026 Rogers Vernon Exec VP of Sales & Mktg. Other 426 84.64 36,057

View all insider transactions →

The company

About the Company

Aehr Test Systems, Inc. bietet Testlösungen für Test, Burn-in und Halbleiterbauelemente auf Waferebene, vereinzelten Dies, Gehäuseteilen und installierten Systemen in den USA, Asien und Europa an.

CEO Insider Trades (12 Mo.)
selling own stock
Employees
138
Headquarters
Fremont, CA
Address
400 Kato Terrace, 94539 Fremont, United States
Phone
510 623 9400
Website
aehr.com
IPO Date
08/14/1997
ISIN
US00760J1088

Management

Management
Name Title Birth Year
Rhea J. Posedel Founder & Independent Chairman 1942
Gayn Erickson President, CEO & Director 1964
Chris P. Siu CFO, Executive VP of Finance & Secretary 1971
Alberto Salamone Executive Vice President of Packaged Parts Burn-in Business 1973
Adil Engineer Chief Operating Officer 1977
Donald P. Richmond II Chief Technology Officer 1956
Vernon Rogers Executive Vice President of Sales & Marketing 1967
Didier Wimmers Executive Vice President of Research & Development 1962

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 11/02/2026 AEHR TEST SYSTEMS (AEHR): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 10/29/2026 AEHR TEST SYSTEMS (AEHR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗
  • 10/20/2026 AEHR TEST SYSTEMS (AEHR): Submission of Matters to a Vote of Security Holders SEC ↗
  • 07/14/2026 AEHR TEST SYSTEMS (AEHR): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?